(19)
(11) EP 2 079 728 A1

(12)

(43) Date of publication:
22.07.2009 Bulletin 2009/30

(21) Application number: 07839443.4

(22) Date of filing: 09.10.2007
(51) International Patent Classification (IPC): 
C07D 401/14(2006.01)
C07D 409/14(2006.01)
C07D 471/04(2006.01)
A61K 31/506(2006.01)
C07D 403/04(2006.01)
C07D 417/14(2006.01)
C07D 487/04(2006.01)
A61P 3/10(2006.01)
(86) International application number:
PCT/US2007/021678
(87) International publication number:
WO 2008/045484 (17.04.2008 Gazette 2008/16)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 10.10.2006 US 851083 P

(71) Applicant: Amgen Inc.
Thousand Oaks, CA 91320-1799 (US)

(72) Inventors:
  • OGAWA, Yasuyuki
    Shinagawa-ku, Tokyo (JP)
  • OKUYAMA, Ryo
    Tokyo (JP)
  • SHIBUYA, Satoshi
    Shinagawa-ku, Tokyo (JP)
  • TODA, Narihiro
    Tokyo (JP)
  • CAO, Zhaodan
    Brisbane, CA 94005 (US)
  • FU, Zice
    Foster City, CA 94404 (US)
  • HAO, Xiaolin
    Foster City, CA 94404 (US)
  • KIM, Yong-jae
    Foster City, CA 94404 (US)
  • LI, Leping
    Burlingame, CA 94010 (US)
  • LIVELY, Sarah E.
    San Carlos, CA 94070 (US)
  • LIZARZABURU, Mike
    San Diego, CA 92115 (US)
  • TIAN, Hui
    Foster City, CA 94404 (US)
  • YU, Ming
    Foster City, CA 94404 (US)

(74) Representative: Ritter, Thomas Kurt et al
Jones Day Prinzregentenstraße 11
80538 München
80538 München (DE)

   


(54) N-ARYL PYRAZOLE COMPOUNDS FOR USE AGAINST DIABETES